News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,131 Results
Type
Article (41263)
Company Profile (302)
Press Release (677555)
Multimedia
Podcasts (97)
Webinars (16)
Section
Business (207338)
Career Advice (2080)
Deals (35928)
Drug Delivery (104)
Drug Development (82553)
Employer Resources (178)
FDA (16368)
Job Trends (15223)
News (350716)
Policy (32993)
Tag
Academia (2577)
Accelerated approval (14)
Adcomms (22)
Allergies (107)
Alliances (50376)
ALS (126)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (175)
Approvals (16409)
Artificial intelligence (361)
Autoimmune disease (39)
Automation (23)
Bankruptcy (364)
Best Places to Work (11757)
BIOSECURE Act (21)
Biosimilars (135)
Biotechnology (211)
Bladder cancer (112)
Brain cancer (42)
Breast cancer (411)
Cancer (3289)
Cardiovascular disease (272)
Career advice (1744)
Career pathing (35)
CAR-T (202)
CDC (37)
Cell therapy (547)
Cervical cancer (27)
Clinical research (68465)
Collaboration (1182)
Company closure (4)
Compensation (833)
Complete response letters (38)
COVID-19 (2682)
CRISPR (66)
C-suite (466)
Cystic fibrosis (120)
Data (3627)
Decentralized trials (2)
Denatured (30)
Depression (82)
Diabetes (376)
Diagnostics (6504)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (164)
Drug pricing (141)
Drug shortages (28)
Duchenne muscular dystrophy (171)
Earnings (89574)
Editorial (49)
Employer branding (23)
Employer resources (152)
Events (117046)
Executive appointments (905)
FDA (18484)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1039)
Gene editing (147)
Generative AI (26)
Gene therapy (430)
GLP-1 (858)
Government (4619)
Grass and pollen (6)
Guidances (331)
Healthcare (18938)
HIV (42)
Huntington's disease (31)
IgA nephropathy (47)
Immunology and inflammation (177)
Immuno-oncology (13)
Indications (45)
Infectious disease (2873)
Inflammatory bowel disease (162)
Inflation Reduction Act (11)
Influenza (76)
Intellectual property (153)
Interviews (330)
IPO (16841)
IRA (49)
Job creations (3846)
Job search strategy (1471)
Kidney cancer (13)
Labor market (64)
Layoffs (537)
Leadership (28)
Legal (7986)
Liver cancer (83)
Longevity (12)
Lung cancer (476)
Lymphoma (242)
Machine learning (21)
Management (58)
Manufacturing (495)
MASH (112)
Medical device (13569)
Medtech (13585)
Mergers & acquisitions (19895)
Metabolic disorders (946)
Multiple sclerosis (111)
NASH (16)
Neurodegenerative disease (153)
Neuropsychiatric disorders (40)
Neuroscience (2345)
NextGen: Class of 2025 (6576)
Non-profit (4511)
Now hiring (54)
Obesity (467)
Opinion (247)
Ovarian cancer (111)
Pain (137)
Pancreatic cancer (140)
Parkinson's disease (200)
Partnered (24)
Patents (361)
Patient recruitment (251)
Peanut (51)
People (58860)
Pharmaceutical (76)
Pharmacy benefit managers (22)
Phase I (21344)
Phase II (30214)
Phase III (22366)
Pipeline (2366)
Policy (241)
Postmarket research (2574)
Preclinical (9087)
Press Release (64)
Prostate cancer (160)
Psychedelics (41)
Radiopharmaceuticals (265)
Rare diseases (518)
Real estate (6050)
Recruiting (68)
Regulatory (23344)
Reports (52)
Research institute (2356)
Resumes & cover letters (355)
Rett syndrome (10)
RNA editing (11)
RSV (55)
Schizophrenia (106)
Series A (167)
Series B (128)
Service/supplier (11)
Sickle cell disease (68)
Special edition (22)
Spinal muscular atrophy (148)
Sponsored (35)
Startups (3678)
State (2)
Stomach cancer (14)
Supply chain (86)
Tariffs (75)
The Weekly (65)
Vaccines (876)
Venture capital (61)
Weight loss (290)
Women's health (54)
Worklife (21)
Date
Last 7 days (476)
Last 30 days (2040)
Last 365 days (31235)
2025 (21563)
2024 (35729)
2023 (40661)
2022 (51786)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35385)
2017 (32634)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29670)
2010 (27706)
Location
Africa (747)
Alabama (74)
Alaska (7)
Arizona (258)
Arkansas (14)
Asia (39754)
Australia (6408)
California (8525)
Canada (2633)
China (792)
Colorado (358)
Connecticut (364)
Delaware (224)
Europe (86003)
Florida (1281)
Georgia (285)
Hawaii (2)
Idaho (60)
Illinois (680)
India (38)
Indiana (402)
Iowa (17)
Japan (257)
Kansas (114)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1140)
Massachusetts (6284)
Michigan (264)
Minnesota (507)
Mississippi (4)
Missouri (101)
Montana (28)
Nebraska (25)
Nevada (97)
New Hampshire (68)
New Jersey (2340)
New Mexico (29)
New York (2326)
North Carolina (1237)
North Dakota (8)
Northern California (3856)
Ohio (260)
Oklahoma (16)
Oregon (36)
Pennsylvania (1798)
Puerto Rico (18)
Rhode Island (41)
South America (1123)
South Carolina (43)
South Dakota (1)
Southern California (3266)
Tennessee (138)
Texas (1317)
United States (31199)
Utah (252)
Virginia (213)
Washington D.C. (75)
Washington State (713)
West Virginia (4)
Wisconsin (71)
719,131 Results for "akeso biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Akeso’s 2025 Interim Results: Commercial Sales Reach New All-Time Highs
August 26, 2025
·
17 min read
Press Releases
Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer
July 24, 2025
·
5 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
September 4, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy
September 2, 2025
·
6 min read
Press Releases
Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy
August 11, 2025
·
5 min read
Press Releases
KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing
September 9, 2025
·
3 min read
Special edition
Deep Dive: Women in Biopharma
BioSpace
did a deep dive into biopharma female executives who navigated difficult markets to lead their companies to high-value exits.
August 27, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints
August 25, 2025
·
5 min read
Press Releases
Akeso Announces Approval to Initiate Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma
August 4, 2025
·
7 min read
Cancer
Summit, Akeso’s Keytruda Challenger Wins Chinese OK as US Approval Questions Linger
With ivonescimab’s data coming solely from China, its prospects in the U.S., where Summit owns the rights, remain up in the air.
April 28, 2025
·
3 min read
·
Tristan Manalac
1 of 71,914
Next
